Navigation Links
Five Ways to Produce siRNAs

Choose the Best Method for Your Research


Many researchers now use small interfering RNAs (siRNAs) to reduce the expression of specific mammalian genes. Here we describe five methods for producing siRNAs for use in mammalian RNAi experiments. Each of these methods has its advantages and drawbacks. The best method for generating siRNAs will depend on the goals of the experiment. This article briefly describes the five methods, presents their advantages and disadvantages, and discusses the types of applications for which they are best suited.


Currently, there are five methods for generating siRNAs for gene silencing studies:

1. Chemical synthesis

2. In vitro transcription

3. Digestion of long dsRNA by an RNase III family enzyme (e.g. Dicer, RNase III)

4. Expression in cells from an siRNA expression plasmid or viral vector

5. Expression in cells from a PCR-derived siRNA expression cassette

The first three methods involve in vitro preparation of siRNAs that are then introduced directly into mammalian cells by lipofection, electroporation, or other technique. The last two methods rely on the introduction of DNA-based vectors and cassettes that express siRNAs within the cells. Table 1, below, summarizes these methods.

Chemical
synthesis

In vitro transcription

RNase III
digestion of
dsRNA

siRNA
Expression
Vector

PCR
Expression Cassette

Requirements

(2) 21-
mer RNA
oligos

(2) 29-mer DNA oligos

Transcription template (200-800 bp region flanked by T7 promoters)

(2) 55-60-mer DNA oligos

(2) ~50-mer DNA oligos

Hands on time

Little to none*

Moderate

Moderate

High

Moderate

Ability to label siRNA (i.e., for analyzing siRNA uptake or localization by fluorescence microscopy)

Yes

Yes

Yes

No

No

Selectability (i.e, antibiotic selection)

No

No

No

Yes

No

Ability to scale up synthesis

Yes

Limited

Limited

Yes

Limited

Relative cost per gene (not including labor)

High

Moderate

Low

Moderate

Moderate

Turnaround time (total preparation/
synthesis time)

4 days to
2 weeks*

24 hours + DNA oligo

1 day + transcription template preparation time

5+ days + DNA oligo

~ 6 hours + DNA oligo

Testing to find optimal siRNA sequence

Required

Required

Not needed

Required

Required

Relative ease of transfection

Good

Good

Good

Fair

Fair

Useful for long term studies

No

No

No

Yes, with selection

No

Monitor transfection efficiency of entire population

No

No

No

Yes

No

Ambion Solution

Ambion's
Custom
siRNA
Synthesis
Service

Silencer
siRNA
Construction
Kit

Silencer siRNA
Cocktail Kit
(RNase III)

pSilencer
siRNA
Expression
Vectors

Silencer
Express
siRNA
Expression
Cassette
Kits

*Depends on purification/deprotection options selected and format (e.g., annealed and ready to transfect versus single strands supplied lyophilized)


siRNA Design

All of the above methods, except digestion of long dsRNA by RNase III, require the design of individual siRNA sequences prior to siRNA preparation. High throughput screening of potential siRNAs and subsequent analysis for knockdown has recently led to the development of predictive algorithms for identifying functional siRNAs. The article Designing a Better siRNA describes an algorithm developed by Ambion's partner, Cenix BioScience. This algorithm results in a high proportion of effective siRNA sequences.


In Vitro Preparation

Method #1: Chemical Synthesis
Although more expensive than any of the other methods, the production of chemically synthesized siRNAs requires almost no effort by the researcher. Ambion, and several other companies, provide high quality, chemically synthesized siRNAs on a custom basis. One of the major benefits of chemical synthesis is the large yield of high purity siRNA. Drawbacks include the price and turnaround times (typically 412 days depending on synthesis and purification options). Because of the relatively high price tag, many researchers find it beneficial to screen siRNA sequences using a less expensive preparation method, such as in vitro transcription, and then have the most effective sequence(s) synthesized chemically. A robust design algorithm that results in a high proportion of effective siRNA sequences is available from Ambion. Improved siRNA design criteria decreases the number of sequences that need to be tested, lowering the costs associated with this option.

Best for:
Studies that require large amounts of a defined ultrapure siRNA sequence

Not suitable for:
Long term studies


Ambion's Solution: Custom, Pre-designed and Validated siRNAs
Custom siRNAs: Ambion provides premium quality, made-to-order siRNAs with your choice of synthesis options. Our standard purification procedure includes deprotection and column purification, and typically yields siRNA that is 90% pure (guaranteed >80% pure). HPLC and PAGE purification is also available, yielding siRNAs that are guaranteed >97% pure. All RNA oligonucleotides are assessed by MALDI-TOF (matrix-assisted laser desorptionionization time-of-flight) mass spectrometry and annealed siRNAs are analyzed by nondenaturing gel or capillary electrophoresis to confirm that the strands are annealed properly.

Pre-designed siRNAs: A design algorithm developed by Ambion's partner, Cenix BioScience, predicts potent and specific siRNA sequences with an impressive success rate (see Designing a Better siRNA for more details). Multiple siRNA designs are available for the human, mouse, and rat genes listed in the public RefSeq database maintained by NCBI. We can also use the algorithm to design siRNAs to other organisms or genes not in the RefSeq database.

Validated siRNAs: Silencer Validated siRNAs are single siRNA duplexes that have been verified experimentally to reduce the expression of individual human genes. Each siRNA has been shown to reduce target gene expression by at least 70% forty-eight hours post transfection by real time RT-PCR. Most of the siRNAs were found to reduce target gene expression by 90% or more. Every Silencer Validated siRNA strand is purified by HPLC and subjected to rigorous quality control measures. The result is the highest quality siRNA with a sequence verified to reduce gene expression.


Method #2: In Vitro Transcription
siRNAs can be readily prepared by in vitro transcription. siRNAs produced by this method are considerably less expensive than their chemically synthesized counterparts, making them a more cost-effective choice for screening siRNA sequences. In addition, they can be produced more quickly than chemically synthesized siRNAs. Once template deoxynucleotides are obtained, the procedure takes about 24 hours, with little hands on time. Disadvantages of this method include the limited scale up potential (although each reaction produces enough siRNA for hundreds of transfections) and the fact that it requires more hands-on time from the researcher compared to chemically synthesized siRNAs which can simply be purchased. It should be noted that in vitro transcribed siRNAs work as well as chemically synthesized siRNAs and usually at lower concentrations -- 0.520 nM vs. 50100 nM concentration per transfection (Figure 1).

Best for:
Screening siRNA sequences or when the price of chemical siRNA synthesis is an obstacle

Not suitable for:
Long term studies or studies that require large amounts of a single siRNA sequence

Ambion's Solution: Silencer siRNA Construction Kit
The Silencer siRNA Construction Kit produces transfection-ready siRNA at a fraction of the cost of chemical synthesis. The kit is based on a patent-pending in vitro transcription method and can generate up to 15 purified siRNAs in less than 24 hours. The cost and time saved using the Silencer siRNA Construction Kit enable screening sequences of more genes and more potential targets within the target gene to find the most potent siRNA.

Figure 1. Use of Chemically Synthesized and in Vitro Transcribed siRNAs to Induce Gene Silencing. siRNAs targeting -actin were prepared by chemical synthesis (Ambion) or by in vitro transcription using Ambion's Silencer siRNA Construction Kit. HeLa cells were plated at 30,000 cells per well in a 24 well tissue culture plate containing glass slides. The cells were transfected 24 hours after plating, using 2 l siPORT Lipid (Ambion) according to the manufacturer's protocol, at a final siRNA concentration of 75 nM. Immunofluorescence analysis was performed 96 hr post transfection using mouse anti-human -actin primary antibody and a FITC conjugated anti-mouse IgG secondary antibody. Photographs were taken using the appropriate fluorescent filters and quantified using MetaMorph software. Note that both siRNA preparation methods resulted in > 95% reduction in -actin protein levels.


Method #3: Digestion of Long dsRNAs to Create an siRNA Cocktail
One of the major drawbacks of all the other methods of siRNA production is the need to design and test several siRNA sequences before an effective one can be identified. Preparation of siRNA cocktails overcomes this limitation. In this method, long dsRNAs are prepared by in vitro transcription using a template that typically encodes a 2001000 nt region of the target mRNA. The dsRNA is then digested in vitro with RNase III (or Dicer) to produce a population, or cocktail, of siRNAs. Since the cocktail contains many different siRNAs, efficient gene knockdown is virtually guaranteed. A representative of one of these experiments is depicted in Figure 2.

The major benefit of this approach is the ability to bypass the testing steps involved in selecting an effective siRNA sequence, saving researchers both time and money (note that RNase III reactions are typically less expensive than those performed with Dicer). One downside of this approach, however, is the theoretical potential for nonspecific silencing effects, particularly for closely related genes. Most research to date indicates that this does not pose a problem (1-4).

Best for:
Fast and inexpensive analysis of loss of function phenotypes

Not suited for:
Long term studies or studies that require a single, defined siRNA sequence

Ambion's Solution: Silencer siRNA Cocktail Kit (RNase III)
With the Silencer siRNA Cocktail Kit (RNase III), a population of siRNAs to a specific target can be prepared in a quick, simple procedure. The population of siRNAs produced by the Silencer siRNA Cocktail Kit (RNase III) elicits gene silencing effects comparable to well designed individual siRNAs, without the need to design and screen individual siRNAs. Ambion scientists have tested many genes and they have yet to see an increase in cytotoxicity. They have also not observed any nonspecific effects associated with the use of siRNA populations as compared to individual, chemically synthesized siRNAs targeting the same gene. To date, Ambion scientists have used this kit successfully with NIH-3T3, HeLa, S3, 293 and BJ cell lines and have knocked down the expression of numerous genes, including c-fos, GAPDH, La, -actin, and Ku-70.

Figure 2. Gene Silencing with the Silencer siRNA Cocktail Kit. A population of siRNAs targeting 200 nt of the Ku-70 mRNA was prepared with the Silencer siRNA Cocktail Kit (RNase III) and transfected into HeLa cells at a final concentration of 100 nM. Cells were analyzed 48 hours later by immunofluorescence. Ku-70 levels were reduced 86% in cells transfected with the siRNA cocktail, compared to non-transfected controls.


In Vivo Expression

All of the methods described so far rely on the in vitro preparation of siRNAs. The use of siRNA expression vectors and PCR-based expression cassettes, however, relies on in vivo transcription of siRNAs from DNA templates introduced into cells. One advantage of these two approaches is that there is no need to work directly with RNA.

Method #4: siRNA Expression Vectors
Most siRNA expression vectors rely on an RNA polymerase III (pol III) promoter to drive the expression of a small hairpin siRNA in mammalian cells (14). RNA pol III was chosen to drive siRNA expression because it naturally expresses relatively large amounts of small RNAs in mammalian cells, it terminates transcription upon incorporating a string of 1-4 uridines, and its transcripts lack poly(A) tails.

To use siRNA expression vectors, two oligodeoxynucleotides encoding the desired short hairpin RNA sequence are ordered, annealed, and cloned into the vector downstream of the promoter. Because cloning is involved, the procedure takes several days, and sequencing the region containing the insert is required. However, this limitation is balanced by the ability to produce large quantities of vector once the vector is shown to work well in gene silencing experiments.

Without a question, the main advantage of siRNA expression vectors is that they are amenable to long term studies. Vectors with antibiotic resistance markers can be used to reduce the expression of targeted genes for several weeks or longer. Transient selection of cells transfected with selectable marker containing plasmids also permits the enrichment of cells that have taken up the plasmid. This can help compensate for low transfection efficiencies in difficult to transfect cells. Recently, several groups including Ambion have begun preparing adenoviral, retroviral, and other viral vectors for siRNA expression (see pSilencer adeno 1.0-CMV). These vectors offer the added advantage that cells can be transduced for gene silencing studies, thus reducing problems associated with inefficient plasmid transfection.

Best for:
Long term and other studies in which antibiotic selection of siRNA containing cells is desired. Retroviruses allow for efficient intergration of the siRNA expression cassette.

Not suitable for:
Screening siRNA sequences (note: screening siRNA sequences is possible, but is time and labor intensive with vectors).

Ambion's Solution: pSilencer siRNA Expression Vectors
pSilencer siRNA Plasmid Expression Vectors feature U6 and H1 pol III promoters, an ampicillin resistance gene; an E. coli origin of replication; and one of three antibiotic selectable markers (neomycin, puromycin, or hygromycin resistance genes). An siRNA template is cloned into the vector resulting in siRNA expression once the plasmid is delivered to cells.

pSilencer-adeno siRNA Expression Vectors are also available, making expression vector delivery much easier in otherwise hard to transfect cells.

Figure 3. Long Term Silencing of GFP with pSilencer 2.1-U6 hygro. HeLa cells expressing cycle 3 GFP were transfected with pSilencer 2.1-U6 hygro containing an insert encoding an siRNA targeting cycle 3 GFP or pSilencer 2.1-U6 hygro without an siRNA-encoding insert. Following transfection, the cells were selected with hygromycin. Three weeks following selection, the cells were analyzed for GFP expression by fluorescence microscopy. Green: GFP. Blue: DAPI stained nuclei. GFP levels were remarkably reduced (94%) in cells transfected with the GFP siRNA-encoding pSilencer 2.1-U6 hygro siRNA Expression Vector as compared to those transfected with an "empty" siRNA expression vector.


Method #5: siRNA Expression Cassettes
siRNA expression cassettes (SECs) are PCR-derived siRNA expression templates that can be introduced into cells directly -- without first being cloned into a vector. Initially described by Castanotto and colleagues (5), SECs include an RNA pol III promoter, a sequence encoding an siRNA hairpin, and an RNA pol III termination site. In contrast to siRNA expression vectors, which require cloning and sequencing prior to use and thus take 12 weeks to prepare, SECs can be generated by PCR in less than a day. SECs thus provide an excellent screening tool to find the most effective siRNA sequence, or to identify the most effective combination of promoter and siRNA in a given cell line. In fact, SECs provide the perfect complement to siRNA expression vectors. By incorporating restriction sites at their ends, SECs found to effectively elicit gene silencing can be readily cloned into a plasmid or viral vector to create an siRNA expression vector. The siRNA expression vector can then be used for stable expression and long term studies. One disadvantage of SECs is that they are not as easily transfected into cells as siRNAs. As new transfection agents and protocols are developed, however, SEC transfection efficiency should increase. Because they are generated by PCR, SECs are not amenable to scale up without being cloned into plasmids. Figure 3 shows data from an experiment in which SECs each containing one of three different promoters were tested for their ability to drive siRNA expression and induce knockdown of c-fos expression.

Best for:
Screening siRNA sequences and testing promoters before preparing vectors

Not suitable for:
Long term studies until cloned into vectors containing selectable markers

Ambion's Solution: Silencer Express siRNA Expression Cassettes
The Silencer Express Kits make it easy to produce siRNA expression cassettes (SECs) with a human H1, human U6, or mouse U6 promoter by PCR for use in RNAi studies. Because a single siRNA template oligonucleotide can be used with any of the three Silencer Express Kits, different promoters can be tested for their capacity to express active siRNAs in a specific cell line. Ambion's Silencer Express Kits provide the reagents necessary to prepare 20 different SECs with either the human H1, human U6, or mouse U6 promoter.

pSEC vectors, which are pre-linearized with the same restriction enzymes and are designed especially for subcloning SECs, are available separately. These ready-to-ligate vectors include a hygromycin, neomycin or puromycin resistance gene to permit selection in mammalian cells.

Figure 4. Variable Reduction in Target Gene Expression Using SECs with Different Promoters. siRNA Expression Cassettes featuring the mouse U6 (Mo-U6), human U6 (Hu-U6), and human H1 (Hu-H1) promoters and encoding a c-fos-specific hairpin siRNA were transfected into HeLa cells. 72 hours post-transfection, the cells were assessed using nuclear staining with DAPI and immunofluorescence using a c-FOS antibody. Non-transfected cells (NT) as well as cells transfected with an SEC expressing a negative control siRNA (scramble) demonstrate wild-type levels of c-FOS. The relative level of reduction in gene expression was quantified and is provided in the bar graph.


siRNA and siRNA Expression Vector Delivery
Once siRNAs or siRNA expression vectors are obtained, they must be delivered to cells. Articles Optimizing Chemical Transfection and Electroporation of siRNAs and Efficient Delivery of siRNAs to Human Primary Cells address delivery of both RNA-based siRNAs and DNA-based expression vectors by transfection and electroporation and provide tips for optimizing this step. Poor delivery efficiency is one of the main reasons RNAi experiments fail (or give false negative results) and deserves much attention.

Analysis of Gene Silencing
Detection and quantitation of gene silencing can be assayed by measuring mRNA or protein levels, or both. The articles on pages 18 and 21 discuss some of these methods. Controls that will help determine siRNA specificity are described in Designing Controls for siRNA Experiments.


Summing It Up
The use of RNAi to induce gene silencing is an exciting new method for creating loss of function phenotypes. Table 1 on page 5 summarizes the five different methods for producing siRNAs. More information about each of these methods can be found throughout this issue. Additional details, including protocols, can be found on the RNAi Resource page at www.ambion.com/RNAi.


back to top


Ordering Information
Cat# Product Name Size 1620 Silencer siRNA Construction Kit 15 siRNA synthesis rxns 1625 Silencer siRNA Cocktail Kit (RNase III) 20 rxns 1680 Silencer Express (Human H1) 20 rxns 1681 Silencer Express (Human U6) 20 rxns 1682 Silencer Express (Mouse U6) 20 rxns 5760 pSilencer 2.1-U6 hygro 20 rxns 5764 pSilencer 2.1-U6 neo 20 rxns 5766 pSilencer 3.1-H1 hygro 20 rxns 5770 pSilencer 3.1-H1 neo 20 rxns 5772 pSEC hygro 20 rxns 7207 pSilencer 1.0-U6 (circular) 20 g 7208 pSilencer 1.0-U6 (linear) 20 rxns 7209 pSilencer 2.0-U6 20 rxns 7210 pSilencer 3.0-H1 20 rxns
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Gram Quantities of MAb Produced with Simple Bioreactor in Serum-Free Perfusion Culture Replacing Ascitic Fluid Production
2. Silencer Validated siRNAs
3. Cenix-Designed siRNAs for 95% of Human and Mouse Genomes
4. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
5. IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!
6. Optimizing Chemical Transfection and Electroporation of siRNAs
7. Delivering siRNAs to Difficult Cell Types
8. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
9. Deliver siRNAs Into Primary Cells
10. Optimize Transfection of siRNAs for RNAi
11. RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Five Ways Produce siRNAs

(Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... P. Horovitz , Ph.D., from its board of directors effective ... in August 2003, and served as its chairman from June ... on the Nominating and Corporate Governance and Audit Committees of ... more than a decade of dedicated service to GenVec, and ...
(Date:10/19/2014)... The Latin American hardware encryption display market report defines ... and forecast of revenue. This market was valued at ... $2,366.8 million by 2018, at a CAGR of 70.3% ... of the Latin American hardware encryption market report to ... also provides a glimpse of the segmentation of the ...
(Date:10/19/2014)... October 19, 2014 The Asia-Pacific Speech ... market in Asia-Pacific with analysis and forecast of revenue. ... in 2014 to $208 million by 2019, at a ... to 2019. , Browse through the TOC of the ... of the in-depth analysis provided. It also provides a ...
(Date:10/18/2014)... October 19, 2014 The “Human ... Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid ... Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to ... drivers, restraints, challenges, opportunities, current market trends, and ... with the estimates and forecasts of the revenue ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5
... US Oncology, Inc . announced that ... counsel, will be departing from the Company, effective November 30, ... had a long and rich history with US Oncology. Beginning ... and consultation as an outside attorney before joining the Company ...
... ST. LOUIS, Nov. 10 At the Board of Directors ... of $.145 per share, an 11.5% increase over the prior ... to shareholders of record on December 1, 2009. , ... Science and High Technology company. Our chemical and biochemical products ...
... Helix Consulting US, a division of London-based Double ... Michael Rizzo to the position of Vice President. ... experienced strategic pricing, reimbursement and market access consultants ... provides product commercialization services to firms in the ...
Cached Biology Technology:US Oncology Announces Retirement of General Counsel Phil Watts 2Double Helix Consulting Enhances its Strategic Product Commercialization Services with Appointment of Michael Rizzo as Vice President 2Double Helix Consulting Enhances its Strategic Product Commercialization Services with Appointment of Michael Rizzo as Vice President 3
(Date:10/17/2014)... knowledge regarding Ebola is critical and pertinent for practicing ... global outbreak and epidemic. The Journal, Disaster Medicine ... issue, Ebola Virus and Public Health, to surround the ... this critical societal moment. , On October 17, ... Clinicians . The primer was prepared by Dr. Eric ...
(Date:10/17/2014)... release is available in German . ... a very few drugs. When treating overdoses, doctors are often ... especially difficult if there is a combination of drugs involved. ... and accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux ... to find an answer to this question. "The task was ...
(Date:10/16/2014)... managers have a new synthesis of recent research findings ... forests in the two states. , The Ecology ... and Washington: A Synthesis of the Relevant Biophysical Science ... report published by the U.S. Forest Service,s Pacific Northwest ... from managers for a synthesis of the large body ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
... of dinosaur unearthed in Mexico is giving scientists fresh insights ... an international research team led by scientists from the Utah ... To date, the dinosaur record from Mexico has been sparse, ... Natural History, Utahs designated natural history museum. The new ...
... HANOVER, N.H. Dartmouth College researchers and colleagues from ... the beginnings of complex life, i.e. vertebrates, to microRNA. ... regulate gene expression, are behind the origin of early ... to understanding the evolutionary origin of our own lineage, ...
... goal of Raphael Kopan, Ph.D., professor of molecular biology ... The moss plant (Physcomitrella patens) studied in the ... Professor and chair of the WUSTL biology department on ... Heres how. The gene presenilin in mammals ...
Cached Biology News:New dinosaur from Mexico offers insights into ancient life on West America 2New dinosaur from Mexico offers insights into ancient life on West America 3New dinosaur from Mexico offers insights into ancient life on West America 4New dinosaur from Mexico offers insights into ancient life on West America 5New dinosaur from Mexico offers insights into ancient life on West America 6Dartmouth researchers find the root of the evolutionary emergence of vertebrates 2Moss protein plays role in Alzheimer's disease 2Moss protein plays role in Alzheimer's disease 3Moss protein plays role in Alzheimer's disease 4